Curcumin Pharmacokinetic and Pharmacodynamic Evidences in Streptozotocin-Diabetic Rats Support the Antidiabetic Activity to Be via Metabolite(s)

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Gutierres, Vânia Ortega ^a   Campos, Michel Leandro ^a   Arcaro, Carlos Alberto ^a   Assis, Renata Pires ^a   Baldan Cimatti, Helen Mariana ^a   Peccinini, Rosângela Gonçalves ^a   Paula Gomes, Silvia ^b   Kettelhut, Isis Carmo ^b   Baviera, Amanda Martins ^a   Brunetti, Iguatemy Lourenço ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; DRUG METABOLITE; GLUCOSE TRANSPORTER 4; PROTEIN KINASE B; YOGHURT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

EID: 84930005718     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/678218     Document Type: Article

References (53)

1. S. C. Gupta, G. Kismali, and B. B. Aggarwal, "Curcumin, a component of turmeric: from farm to pharmacy," BioFactors, vol. 39, no. 1, pp. 2-13, 2013.
2. R. L. Thangapazham, A. Puri, S. Tele, R. Blumenthal, and R. K. Maheshwari, "Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells," International Journal of Oncology, vol. 32, no. 5, pp. 1119-1123, 2008.
3. L. M. Howells, J. Mahale, S. Sale et al., "Translating curcumin to the clinic for lung cancer prevention: evaluation of the preclinical evidence for its utility in primary, secondary, and tertiary prevention strategies," Journal of Pharmacology and Experimental Therapeutics, vol. 350, no. 3, pp. 483-494, 2014.
4. W. Wongcharoen and A. Phrommintikul, "The protective role of curcumin in cardiovascular diseases," International Journal of Cardiology, vol. 133, no. 2, pp. 145-151, 2009.
5. B. B. Aggarwal, "Targeting Inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals," Annual Review of Nutrition, vol. 30, pp. 173-199, 2010.
6. D.-W. Zhang, M. Fu, S.-H. Gao, and J.-L. Liu, "Curcumin and diabetes: a systematic review," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 636053, 16 pages, 2013.
7. M.-H. Pan, T.-M. Huang, and J.-K. Lin, "Biotransformation of curcumin through reduction and glucuronidation in mice," Drug Metabolism and Disposition, vol. 27, no. 4, pp. 486-494, 1999.
8. S. K. Vareed, M. Kakarala, M. T. Ruffin et al., "Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects," Cancer Epidemiology Biomarkers & Prevention, vol. 17, no. 6, pp. 1411-1417, 2008.
9. P. Anand, S. G. Thomas, A. B. Kunnumakkara et al., "Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature," Biochemical Pharmacology, vol. 76, no. 11, pp. 1590-1611, 2008.
10. Y. Gao, Z. Li, M. Sun et al., "Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer," Drug Development and Industrial Pharmacy, vol. 36, no. 10, pp. 1225-1234, 2010.
11. J. Cui, B. Yu, Y. Zhao et al., "Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems," International Journal of Pharmaceutics, vol. 371, no. 1-2, pp. 148-155, 2009.
12. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P. S. S. R. Srinivas, "Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers," Planta Medica, vol. 64, no. 4, pp. 353-356, 1997.
13. S. Prasad, A. K. Tyagi, and B. B. Aggarwal, "Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice," Cancer Research and Treatment, vol. 46, no. 1, pp. 2-18, 2014.
14. V. O. Gutierres, C. M. Pinheiro, R. P. Assis, R. C. Vendramini, M. T. Pepato, and I. L. Brunetti, "Curcumin-supplemented yoghurt improves physiological and biochemical markers of experimental diabetes," British Journal of Nutrition, vol. 108, no. 3, pp. 440-448, 2012.
15. C. A. Arcaro, V. O. Gutierres, R. P. Assis et al., "Piperine, a natural bioenhancer, nullifies the antidiabetic and antioxidant activities of curcumin in streptozotocin-diabetic rats," PLoS ONE, vol. 9, no. 12, Article ID e113993, 2014.
16. P. Trinder, "Determination of blood glucose using 4-amino phenazone as oxygen acceptor," Journal of Clinical Pathology, vol. 22, no. 2, p. 246, 1969.
17. M. L. de Campos, H. M. Baldan-Cimatti, M. G. Davanço et al., "Pharmacokinetic profile of a new diclofenac prodrug without gastroulcerogenic effect," Drug Metabolism Letters, vol. 6, no. 4, pp. 235-241, 2013.
18. K. Lundbaek, "Intravenous glucose tolerance as a tool in definition and diagnosis of diabetes mellitus," British Medical Journal, vol. 1, no. 5291, pp. 1507-1513, 1962.
19. M. M. Bradford, "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding," Analytical Biochemistry, vol. 72, no. 1-2, pp. 248-254, 1976.
20. S. Nishiumi and H. Ashida, "Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane," Bioscience, Biotechnology, and Biochemistry, vol. 71, no. 9, pp. 2343-2346, 2007.
21. U. K. Laemmli, "Cleavage of structural proteins during the assembly of the head of bacteriophage T4," Nature, vol. 227, no. 5259, pp. 680-685, 1970.
22. H. Towbin, T. Staehelin, and J. Gordon, "Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications," Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 9, pp. 4350-4354, 1979.
23. K. Y. Yang, L. C. Lin, T. Y. Tseng, S. C. Wang, and T. H. Tsai, "Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS," Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 853, no. 1-2, pp. 183-189, 2007.
24. J.-K. Lin, M.-H. Pan, and S.-Y. Lin-Shiau, "Recent studies on the biofunctions and biotransformations of curcumin," BioFactors, vol. 13, no. 1-4, pp. 153-158, 2000.
25. L. Zhongfa, M. Chiu, J. Wang et al., "Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice," Cancer Chemotherapy and Pharmacology, vol. 69, no. 3, pp. 679-689, 2012.
26. A. Asai and T. Miyazawa, "Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue," Journal of Nutrition, vol. 131, no. 11, pp. 2932-2935, 2001.
27. K. Karthikesan, L. Pari, and V. P. Menon, "Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nicotinamide-induced diabetic rats," General Physiology and Biophysics, vol. 29, no. 1, pp. 23-30, 2010.
28. Y. Nakamura, Y. Ohto, A. Murakami, T. Osawa, and H. Ohigashi, "Inhibitory effects of curcumin and tetrahydrocurcuminoids on the tumor promoter-induced reactive oxygen species generation in leukocytes in vitro and in vivo," Japanese Journal of Cancer Research, vol. 89, no. 4, pp. 361-370, 1998.
29. L. Pari and D. R. Amali, "Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats," Journal of Pharmacy & Pharmaceutical Sciences, vol. 8, no. 1, pp. 115-123, 2005.
30. L. Pari and P. Murugan, "Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats," Journal of Basic and Clinical Physiology and Pharmacology, vol. 16, no. 4, pp. 257-274, 2005.
31. K. Okada, C. Wangpoengtrakul, T. Tanaka, S. Toyokuni, K. Uchida, and T. Osawa, "Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice," Journal of Nutrition, vol. 131, no. 8, pp. 2090-2095, 2001.
32. P. L. Toutain and A. Bousquet-Mélou, "Plasma terminal half-life,"Journal of Veterinary Pharmacology and Therapeutics, vol. 27, no. 6, pp. 427-439, 2004.
33. S. Lenzen, "The mechanisms of alloxan- and streptozotocin-induced diabetes," Diabetologia, vol. 51, no. 2, pp. 216-226, 2008.
34. K. Kagami, H. Morita, K. Onda, T. Hirano, and K. Oka, "Protective effect of caffeine on streptozotocin-induced beta-cell damage in rats," Journal of Pharmacy and Pharmacology, vol. 60, no. 9, pp. 1161-1165, 2008.
35. T. Kadowaki, M. Kasuga, Y. Akanuma, O. Ezaki, and F. Takaku, "Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic rats," The Journal of Biological Chemistry, vol. 259, no. 22, pp. 14208-14216, 1984.
36. F. Giorgino, J.-H. Chen, and R. J. Smith, "Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight nonreceptor protein in vivo in skeletal muscle of streptozotocin-induced diabetic rats: effects of insulin and glucose," Endocrinology, vol. 130, no. 3, pp. 1433-1444, 1992.
37. J. J. Hulmi, M. Silvennoinen, M. Lehti, R. Kivelä, and H. Kainulainen, "Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy," The American Journal of Physiology - Endocrinology and Metabolism, vol. 302, no. 3, pp. E307-E315, 2012.
38. B. B. Kahn, L. Rossetti, H. F. Lodish, and M. J. Charron, "Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats," The Journal of Clinical Investigation, vol. 87, no. 6, pp. 2197-2206, 1991.
39. C. K. Atal, R. K. Dubey, and J. Singh, "Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism," Journal of Pharmacology and Experimental Therapeutics, vol. 232, no. 1, pp. 258-262, 1985.
40. K. Srinivasan, "Black pepper and its pungent principle-piperine: a review of diverse physiological effects," Critical Reviews in Food Science and Nutrition, vol. 47, no. 8, pp. 735-748, 2007.
41. A. M. Neyrinck, M. Alligier, P. B. Memvanga et al., "Curcuma longa extract associated with white pepper lessens high fat diet-induced inflammation in subcutaneous adipose tissue," PLoS ONE, vol. 8, no. 11, Article ID e81252, 2013.
42. Y.-T. Deng, T.-W. Chang, M.-S. Lee, and J.-K. Lin, "Suppression of free fatty acid-induced insulin resistance by phytopolyphenols in C2C12 mouse skeletal muscle cells," Journal of Agricultural and Food Chemistry, vol. 60, no. 4, pp. 1059-1066, 2012.
43. T.-C. Cheng, C.-S. Lin, C.-C. Hsu, L.-J. Chen, K.-C. Cheng, and J.-T. Cheng, "Activation of muscarinic M-1 cholinoceptors by curcumin to increase glucose uptake into skeletal muscle isolated from Wistar rats," Neuroscience Letters, vol. 465, no. 3, pp. 238-241, 2009.
44. L.-X. Na, Y.-L. Zhang, Y. Li et al., "Curcumin improves insulin resistance in skeletal muscle of rats," Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 7, pp. 526-533, 2011.
45. P. Murugan, L. Pari, and C. A. Rao, "Effect of tetrahydrocurcumin on insulin receptor status in type 2 diabetic rats: studies on insulin binding to erythrocytes," Journal of Biosciences, vol. 33, no. 1, pp. 63-72, 2008.
46. A. Liu, H. Lou, L. Zhao, and P. Fan, "Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin," Journal of Pharmaceutical and Biomedical Analysis, vol. 40, no. 3, pp. 720-727, 2006.
47. T. H. Marczylo, R. D. Verschoyle, D. N. Cooke, P. Morazzoni, W. P. Steward, and A. J. Gescher, "Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine," Cancer Chemotherapy and Pharmacology, vol. 60, no. 2, pp. 171-177, 2007.
48. K. Maiti, K. Mukherjee, A. Gantait, B. P. Saha, and P. K. Mukherjee, "Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats,"International Journal of Pharmaceutics, vol. 330, no. 1-2, pp. 155-163, 2007.
49. V. Kakkar, S. Singh, D. Singla et al., "Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats," Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 878, no. 32, pp. 3427-3431, 2010.
50. J. LJi, Y. Jiang, J. Wen, G. Fan, Y. Wu, and C. Zhang, "A rapid and simple HPLC method for the determination of curcumin in rat plasma: assay development, validation and application to a pharmacokinetic study of curcumin liposome," Biomedical Chromatography, vol. 23, no. 11, pp. 1201-1207, 2009.
51. J. Shaikh, D. D. Ankola, V. Beniwal, D. Singh, and M. N. V. R. Kumar, "Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer," European Journal of Pharmaceutical Sciences, vol. 37, no. 3-4, pp. 223-230, 2009.
52. N. M. Khalil, T. C. F. do Nascimento, D. M. Casa et al., "Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats," Colloids and Surfaces B: Biointerfaces, vol. 101, pp. 353-360, 2013.
53. R. Ravichandran, "Pharmacokinetic study of nanoparticulate curcumin: oral formulation for enhanced bioavailability," Journal of Biomaterials and Nanobiotechnology, vol. 4, no. 3, pp. 291-299, 2013.